Literature DB >> 9182725

Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1.

I M Clark1, A D Rowan, D R Edwards, T Bech-Hansen, D A Mann, M J Bahr, T E Cawston.   

Abstract

The active forms of all of the matrix metalloproteinases (MMPs) are inhibited by a family of specific inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). Inhibition represents a major level of control of MMP activity. A detailed knowledge of the mechanisms controlling TIMP gene expression is therefore important. We have isolated a genomic clone of the human TIMP-1 gene. A 3 kbp XbaI fragment has been sequenced; this fragment contains 1718 bp 5' flanking sequences, exon 1, a 929 bp intron 1 and part of exon 2. Computer analysis reveals 10 consensus sequences for Sp1, six for activating protein 1 (AP-1), six for polyoma enhancer A3 (PEA3), 12 for AP-2 and five CCAAT boxes. The region hybridizing with a murine TIMP-1 promoter fragment has been subcloned and analysed further. RNase protection identifies six transcription start points, making exon 1 up to 48 bp in length. Transient transfection of promoter-chloramphenicol O-acetyltransferase reporter constructs into primary human connective tissue fibroblasts shows that a 904 bp fragment that hybridizes to a murine TIMP-1 promoter fragment contains a functional promoter. Constructs of -738/+95 to -194/+21 are inducible with serum or phorbol ester to a similar extent to the endogenous TIMP-1 gene. These results and further mapping with 5' deletion mutants from the -738/+95 region have demonstrated that an AP-1 site at -92/-86 is essential for basal expression of the gene. Point mutations within this region have further confirmed the role of this site, along with a more minor role for a neighbouring PEA3 site, in basal expression. Deletions from the 3' end also implicate a region across the exon 1/intron 1 boundary and especially +21 to +58 in basal expression. The +21/+58 region contains a putative binding site for the transcription factor leader-binding protein 1 (LBP-1). Gel-shift analysis shows that protein binds specifically to this region, but competition studies suggest that it is unlikely to be LBP-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182725      PMCID: PMC1218473          DOI: 10.1042/bj3240611

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

2.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice.

Authors:  A M Flenniken; B R Williams
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

5.  Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts.

Authors:  T Sato; A Ito; Y Mori
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

6.  Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene.

Authors:  C E Campbell; A M Flenniken; D Skup; B R Williams
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter.

Authors:  M Bugno; L Graeve; P Gatsios; A Koj; P C Heinrich; J Travis; T Kordula
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

9.  Presence of transcription regulatory elements within an intron of the virus-inducible murine TIMP gene.

Authors:  B Coulombe; A Ponton; L Daigneault; B R Williams; D Skup
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Authors:  D R Edwards; G Murphy; J J Reynolds; S E Whitham; A J Docherty; P Angel; J K Heath
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  14 in total

1.  EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.

Authors:  Balachandar Venkatesan; Anthony J Valente; Sumanth D Prabhu; Prakashsrinivasan Shanmugam; Patrice Delafontaine; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2010-06-09       Impact factor: 5.000

2.  CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1.

Authors:  Jerel Fields; Jessica Gardner-Mercer; Kathleen Borgmann; Ian Clark; Anuja Ghorpade
Journal:  J Neurochem       Date:  2011-03-14       Impact factor: 5.372

Review 3.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization.

Authors:  T Kobayashi; J Kishimoto; Y Ge; W Jin; D L Hudson; N Ouahes; R Ehama; H Shinkai; R E Burgeson
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

5.  Global gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary Carcinoma.

Authors:  Shanjin Cao; Zhaoying Xiang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2004-10       Impact factor: 11.530

6.  Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.

Authors:  Zahra Kadri; Leila Maouche-Chretien; Heather M Rooke; Stuart H Orkin; Paul-Henri Romeo; Patrick Mayeux; Philippe Leboulch; Stany Chretien
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation.

Authors:  Alok Dhar; Jessica Gardner; Kathleen Borgmann; Li Wu; Anuja Ghorpade
Journal:  J Neurosci Res       Date:  2006-05-15       Impact factor: 4.164

8.  Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells.

Authors:  O Kustikova; D Kramerov; M Grigorian; V Berezin; E Bock; E Lukanidin; E Tulchinsky
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women.

Authors:  Anna Stanisławska-Sachadyn; Karen S Brown; Laura E Mitchell; Jayne V Woodside; Ian S Young; John M Scott; Liam Murray; Colin A Boreham; Helene McNulty; J J Strain; Alexander S Whitehead
Journal:  Hum Genet       Date:  2008-02-05       Impact factor: 4.132

10.  A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate.

Authors:  Renee D Kalmbach; Silvina F Choumenkovitch; Aron P Troen; Paul F Jacques; Ralph D'Agostino; Jacob Selhub
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.